Use of Immunotherapy in Patients With Cancer During the COVID-19 Pandemic.
Identifieur interne : 000088 ( Main/Exploration ); précédent : 000087; suivant : 000089Use of Immunotherapy in Patients With Cancer During the COVID-19 Pandemic.
Auteurs : Andrey Soares [Brésil] ; Fabio A. Schutz [Brésil] ; Diogo Assed Bastos [Brésil] ; Denis Jardim [Brésil] ; Fernando Sabino Marques Montiero [Brésil]Source :
- Oncology (Williston Park, N.Y.) [ 0890-9091 ] ; 2020.
Descripteurs français
- KwdFr :
- Anticorps monoclonaux (effets indésirables), Anticorps monoclonaux (usage thérapeutique), Antinéoplasiques immunologiques (effets indésirables), Antinéoplasiques immunologiques (usage thérapeutique), Betacoronavirus (MeSH), Carboplatine (administration et posologie), Carcinome épidermoïde (imagerie diagnostique), Carcinome épidermoïde (thérapie), Chimioradiothérapie (MeSH), Chimiothérapie de consolidation (MeSH), Diagnostic différentiel (MeSH), Femelle (MeSH), Humains (MeSH), Infections à coronavirus (diagnostic), Paclitaxel (administration et posologie), Pandémies (MeSH), Pneumopathie infectieuse (diagnostic), Pneumopathie infectieuse (induit chimiquement), Pneumopathie virale (diagnostic), Poumon (imagerie diagnostique), Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique), Sujet âgé (MeSH), Tumeurs du poumon (imagerie diagnostique), Tumeurs du poumon (thérapie).
- MESH :
- administration et posologie : Carboplatine, Paclitaxel.
- diagnostic : Infections à coronavirus, Pneumopathie infectieuse, Pneumopathie virale.
- effets indésirables : Anticorps monoclonaux, Antinéoplasiques immunologiques.
- imagerie diagnostique : Carcinome épidermoïde, Poumon, Tumeurs du poumon.
- induit chimiquement : Pneumopathie infectieuse.
- thérapie : Carcinome épidermoïde, Tumeurs du poumon.
- usage thérapeutique : Anticorps monoclonaux, Antinéoplasiques immunologiques, Protocoles de polychimiothérapie antinéoplasique.
- Betacoronavirus, Chimioradiothérapie, Chimiothérapie de consolidation, Diagnostic différentiel, Femelle, Humains, Pandémies, Sujet âgé.
English descriptors
- KwdEn :
- Aged (MeSH), Antibodies, Monoclonal (adverse effects), Antibodies, Monoclonal (therapeutic use), Antineoplastic Agents, Immunological (adverse effects), Antineoplastic Agents, Immunological (therapeutic use), Antineoplastic Combined Chemotherapy Protocols (therapeutic use), Betacoronavirus (MeSH), Carboplatin (administration & dosage), Carcinoma, Squamous Cell (diagnostic imaging), Carcinoma, Squamous Cell (therapy), Chemoradiotherapy (MeSH), Consolidation Chemotherapy (MeSH), Coronavirus Infections (diagnosis), Diagnosis, Differential (MeSH), Female (MeSH), Humans (MeSH), Lung (diagnostic imaging), Lung Neoplasms (diagnostic imaging), Lung Neoplasms (therapy), Paclitaxel (administration & dosage), Pandemics (MeSH), Pneumonia (chemically induced), Pneumonia (diagnosis), Pneumonia, Viral (diagnosis).
- MESH :
- chemical , administration & dosage : Carboplatin, Paclitaxel.
- chemical , adverse effects : Antibodies, Monoclonal, Antineoplastic Agents, Immunological.
- chemical , therapeutic use : Antibodies, Monoclonal, Antineoplastic Agents, Immunological.
- chemically induced : Pneumonia.
- diagnosis : Coronavirus Infections, Pneumonia, Pneumonia, Viral.
- diagnostic imaging : Carcinoma, Squamous Cell, Lung, Lung Neoplasms.
- therapeutic use : Antineoplastic Combined Chemotherapy Protocols.
- therapy : Carcinoma, Squamous Cell, Lung Neoplasms.
- Aged, Betacoronavirus, Chemoradiotherapy, Consolidation Chemotherapy, Diagnosis, Differential, Female, Humans, Pandemics.
Abstract
In an asymptomatic 77-yearold woman, former 55 packyears smoker, a routine X-ray showed a 45-mm superior left lobe lesion. A chest CT scan confirmed a 36-mm superior left lobe lesion and an aortic-pulmonary lymph node enlargement measuring 42 mm, suspicious for neoplasia. A PET-CT scan showed an elevated uptake in the primary lesion, in the aortic-pulmonary lymph node, and in the left hilar lymph node with a standardized uptake value - 40 and 4.3, respectively. CT-guided lung biopsy showed a lung squamous cell carcinoma. An endobronchial ultrasound-guided transbronchial needle aspiration for lymph-node staging was negative for lymph node spread. Brain MRI was negative. Final staging was determined to be a IIIA (T2bN2) squamous cell carcinoma of the lung.
DOI: 10.46883/ONC.2020.3409.0370
PubMed: 32965669
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Use of Immunotherapy in Patients With Cancer During the COVID-19 Pandemic.</title>
<author><name sortKey="Soares, Andrey" sort="Soares, Andrey" uniqKey="Soares A" first="Andrey" last="Soares">Andrey Soares</name>
<affiliation wicri:level="2"><nlm:affiliation>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul</wicri:regionArea>
<placeName><region type="state">Rio Grande do Sul</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Hospital Israelita Albert Einstein, Sao Paulo, Sao Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Oncology, Hospital Israelita Albert Einstein, Sao Paulo, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Centro Paulista de Oncologia-Oncoclínicas, Sao Paulo, Sao Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Oncology, Centro Paulista de Oncologia-Oncoclínicas, Sao Paulo, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Schutz, Fabio A" sort="Schutz, Fabio A" uniqKey="Schutz F" first="Fabio A" last="Schutz">Fabio A. Schutz</name>
<affiliation wicri:level="2"><nlm:affiliation>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul</wicri:regionArea>
<placeName><region type="state">Rio Grande do Sul</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Beneficência Portuguesa de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Beneficência Portuguesa de Sao Paulo, Sao Paulo, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bastos, Diogo Assed" sort="Bastos, Diogo Assed" uniqKey="Bastos D" first="Diogo Assed" last="Bastos">Diogo Assed Bastos</name>
<affiliation wicri:level="2"><nlm:affiliation>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul</wicri:regionArea>
<placeName><region type="state">Rio Grande do Sul</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jardim, Denis" sort="Jardim, Denis" uniqKey="Jardim D" first="Denis" last="Jardim">Denis Jardim</name>
<affiliation wicri:level="2"><nlm:affiliation>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul</wicri:regionArea>
<placeName><region type="state">Rio Grande do Sul</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marques Montiero, Fernando Sabino" sort="Marques Montiero, Fernando Sabino" uniqKey="Marques Montiero F" first="Fernando Sabino" last="Marques Montiero">Fernando Sabino Marques Montiero</name>
<affiliation wicri:level="2"><nlm:affiliation>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul</wicri:regionArea>
<placeName><region type="state">Rio Grande do Sul</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Department of Oncology and Hematology, Hospital Santa Lucia, Brasilia, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Oncology and Hematology, Hospital Santa Lucia, Brasilia</wicri:regionArea>
<wicri:noRegion>Brasilia</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, Hospital Universitário de Brasília, Brasilia, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Oncology, Hospital Universitário de Brasília, Brasilia</wicri:regionArea>
<wicri:noRegion>Brasilia</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2"><nlm:affiliation>School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul</wicri:regionArea>
<placeName><region type="state">Rio Grande do Sul</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32965669</idno>
<idno type="pmid">32965669</idno>
<idno type="doi">10.46883/ONC.2020.3409.0370</idno>
<idno type="wicri:Area/Main/Corpus">000116</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000116</idno>
<idno type="wicri:Area/Main/Curation">000116</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000116</idno>
<idno type="wicri:Area/Main/Exploration">000116</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Use of Immunotherapy in Patients With Cancer During the COVID-19 Pandemic.</title>
<author><name sortKey="Soares, Andrey" sort="Soares, Andrey" uniqKey="Soares A" first="Andrey" last="Soares">Andrey Soares</name>
<affiliation wicri:level="2"><nlm:affiliation>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul</wicri:regionArea>
<placeName><region type="state">Rio Grande do Sul</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Hospital Israelita Albert Einstein, Sao Paulo, Sao Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Oncology, Hospital Israelita Albert Einstein, Sao Paulo, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Centro Paulista de Oncologia-Oncoclínicas, Sao Paulo, Sao Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Oncology, Centro Paulista de Oncologia-Oncoclínicas, Sao Paulo, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Schutz, Fabio A" sort="Schutz, Fabio A" uniqKey="Schutz F" first="Fabio A" last="Schutz">Fabio A. Schutz</name>
<affiliation wicri:level="2"><nlm:affiliation>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul</wicri:regionArea>
<placeName><region type="state">Rio Grande do Sul</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Beneficência Portuguesa de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Beneficência Portuguesa de Sao Paulo, Sao Paulo, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bastos, Diogo Assed" sort="Bastos, Diogo Assed" uniqKey="Bastos D" first="Diogo Assed" last="Bastos">Diogo Assed Bastos</name>
<affiliation wicri:level="2"><nlm:affiliation>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul</wicri:regionArea>
<placeName><region type="state">Rio Grande do Sul</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jardim, Denis" sort="Jardim, Denis" uniqKey="Jardim D" first="Denis" last="Jardim">Denis Jardim</name>
<affiliation wicri:level="2"><nlm:affiliation>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul</wicri:regionArea>
<placeName><region type="state">Rio Grande do Sul</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marques Montiero, Fernando Sabino" sort="Marques Montiero, Fernando Sabino" uniqKey="Marques Montiero F" first="Fernando Sabino" last="Marques Montiero">Fernando Sabino Marques Montiero</name>
<affiliation wicri:level="2"><nlm:affiliation>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul</wicri:regionArea>
<placeName><region type="state">Rio Grande do Sul</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Department of Oncology and Hematology, Hospital Santa Lucia, Brasilia, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Oncology and Hematology, Hospital Santa Lucia, Brasilia</wicri:regionArea>
<wicri:noRegion>Brasilia</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, Hospital Universitário de Brasília, Brasilia, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Oncology, Hospital Universitário de Brasília, Brasilia</wicri:regionArea>
<wicri:noRegion>Brasilia</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2"><nlm:affiliation>School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul</wicri:regionArea>
<placeName><region type="state">Rio Grande do Sul</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Oncology (Williston Park, N.Y.)</title>
<idno type="ISSN">0890-9091</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term>
<term>Antibodies, Monoclonal (adverse effects)</term>
<term>Antibodies, Monoclonal (therapeutic use)</term>
<term>Antineoplastic Agents, Immunological (adverse effects)</term>
<term>Antineoplastic Agents, Immunological (therapeutic use)</term>
<term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Carboplatin (administration & dosage)</term>
<term>Carcinoma, Squamous Cell (diagnostic imaging)</term>
<term>Carcinoma, Squamous Cell (therapy)</term>
<term>Chemoradiotherapy (MeSH)</term>
<term>Consolidation Chemotherapy (MeSH)</term>
<term>Coronavirus Infections (diagnosis)</term>
<term>Diagnosis, Differential (MeSH)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Lung (diagnostic imaging)</term>
<term>Lung Neoplasms (diagnostic imaging)</term>
<term>Lung Neoplasms (therapy)</term>
<term>Paclitaxel (administration & dosage)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia (chemically induced)</term>
<term>Pneumonia (diagnosis)</term>
<term>Pneumonia, Viral (diagnosis)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps monoclonaux (effets indésirables)</term>
<term>Anticorps monoclonaux (usage thérapeutique)</term>
<term>Antinéoplasiques immunologiques (effets indésirables)</term>
<term>Antinéoplasiques immunologiques (usage thérapeutique)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Carboplatine (administration et posologie)</term>
<term>Carcinome épidermoïde (imagerie diagnostique)</term>
<term>Carcinome épidermoïde (thérapie)</term>
<term>Chimioradiothérapie (MeSH)</term>
<term>Chimiothérapie de consolidation (MeSH)</term>
<term>Diagnostic différentiel (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (diagnostic)</term>
<term>Paclitaxel (administration et posologie)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie infectieuse (diagnostic)</term>
<term>Pneumopathie infectieuse (induit chimiquement)</term>
<term>Pneumopathie virale (diagnostic)</term>
<term>Poumon (imagerie diagnostique)</term>
<term>Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique)</term>
<term>Sujet âgé (MeSH)</term>
<term>Tumeurs du poumon (imagerie diagnostique)</term>
<term>Tumeurs du poumon (thérapie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Carboplatin</term>
<term>Paclitaxel</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antibodies, Monoclonal</term>
<term>Antineoplastic Agents, Immunological</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antibodies, Monoclonal</term>
<term>Antineoplastic Agents, Immunological</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Carboplatine</term>
<term>Paclitaxel</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Pneumonia</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie infectieuse</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Carcinoma, Squamous Cell</term>
<term>Lung</term>
<term>Lung Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Anticorps monoclonaux</term>
<term>Antinéoplasiques immunologiques</term>
</keywords>
<keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Carcinome épidermoïde</term>
<term>Poumon</term>
<term>Tumeurs du poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="induit chimiquement" xml:lang="fr"><term>Pneumopathie infectieuse</term>
</keywords>
<keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Carcinoma, Squamous Cell</term>
<term>Lung Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Carcinome épidermoïde</term>
<term>Tumeurs du poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticorps monoclonaux</term>
<term>Antinéoplasiques immunologiques</term>
<term>Protocoles de polychimiothérapie antinéoplasique</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Betacoronavirus</term>
<term>Chemoradiotherapy</term>
<term>Consolidation Chemotherapy</term>
<term>Diagnosis, Differential</term>
<term>Female</term>
<term>Humans</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Betacoronavirus</term>
<term>Chimioradiothérapie</term>
<term>Chimiothérapie de consolidation</term>
<term>Diagnostic différentiel</term>
<term>Femelle</term>
<term>Humains</term>
<term>Pandémies</term>
<term>Sujet âgé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In an asymptomatic 77-yearold woman, former 55 packyears smoker, a routine X-ray showed a 45-mm superior left lobe lesion. A chest CT scan confirmed a 36-mm superior left lobe lesion and an aortic-pulmonary lymph node enlargement measuring 42 mm, suspicious for neoplasia. A PET-CT scan showed an elevated uptake in the primary lesion, in the aortic-pulmonary lymph node, and in the left hilar lymph node with a standardized uptake value - 40 and 4.3, respectively. CT-guided lung biopsy showed a lung squamous cell carcinoma. An endobronchial ultrasound-guided transbronchial needle aspiration for lymph-node staging was negative for lymph node spread. Brain MRI was negative. Final staging was determined to be a IIIA (T2bN2) squamous cell carcinoma of the lung.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32965669</PMID>
<DateCompleted><Year>2020</Year>
<Month>10</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>10</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0890-9091</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>34</Volume>
<Issue>9</Issue>
<PubDate><Year>2020</Year>
<Month>09</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Oncology (Williston Park, N.Y.)</Title>
<ISOAbbreviation>Oncology (Williston Park)</ISOAbbreviation>
</Journal>
<ArticleTitle>Use of Immunotherapy in Patients With Cancer During the COVID-19 Pandemic.</ArticleTitle>
<Pagination><MedlinePgn>370-376</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.46883/ONC.2020.3409.0370</ELocationID>
<Abstract><AbstractText>In an asymptomatic 77-yearold woman, former 55 packyears smoker, a routine X-ray showed a 45-mm superior left lobe lesion. A chest CT scan confirmed a 36-mm superior left lobe lesion and an aortic-pulmonary lymph node enlargement measuring 42 mm, suspicious for neoplasia. A PET-CT scan showed an elevated uptake in the primary lesion, in the aortic-pulmonary lymph node, and in the left hilar lymph node with a standardized uptake value - 40 and 4.3, respectively. CT-guided lung biopsy showed a lung squamous cell carcinoma. An endobronchial ultrasound-guided transbronchial needle aspiration for lymph-node staging was negative for lymph node spread. Brain MRI was negative. Final staging was determined to be a IIIA (T2bN2) squamous cell carcinoma of the lung.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Soares</LastName>
<ForeName>Andrey</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Oncology, Hospital Israelita Albert Einstein, Sao Paulo, Sao Paulo, Brazil.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Oncology, Centro Paulista de Oncologia-Oncoclínicas, Sao Paulo, Sao Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Schutz</LastName>
<ForeName>Fabio A</ForeName>
<Initials>FA</Initials>
<AffiliationInfo><Affiliation>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Beneficência Portuguesa de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bastos</LastName>
<ForeName>Diogo Assed</ForeName>
<Initials>DA</Initials>
<AffiliationInfo><Affiliation>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo, Brazil.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jardim</LastName>
<ForeName>Denis</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo, Brazil.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Oncology, Hospital Sírio-Libanês, Sao Paulo, Sao Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Marques Montiero</LastName>
<ForeName>Fernando Sabino</ForeName>
<Initials>FS</Initials>
<AffiliationInfo><Affiliation>Latin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Oncology and Hematology, Hospital Santa Lucia, Brasilia, Brazil.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Oncology, Hospital Universitário de Brasília, Brasilia, Brazil.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Oncology (Williston Park)</MedlineTA>
<NlmUniqueID>8712059</NlmUniqueID>
<ISSNLinking>0890-9091</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000074322">Antineoplastic Agents, Immunological</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>28X28X9OKV</RegistryNumber>
<NameOfSubstance UI="C000613593">durvalumab</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>BG3F62OND5</RegistryNumber>
<NameOfSubstance UI="D016190">Carboplatin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>P88XT4IS4D</RegistryNumber>
<NameOfSubstance UI="D017239">Paclitaxel</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000074322" MajorTopicYN="N">Antineoplastic Agents, Immunological</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016190" MajorTopicYN="N">Carboplatin</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D059248" MajorTopicYN="N">Chemoradiotherapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D060830" MajorTopicYN="N">Consolidation Chemotherapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017239" MajorTopicYN="N">Paclitaxel</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>9</Month>
<Day>23</Day>
<Hour>12</Hour>
<Minute>14</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>9</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>10</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32965669</ArticleId>
<ArticleId IdType="doi">10.46883/ONC.2020.3409.0370</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Brésil</li>
</country>
<region><li>Rio Grande do Sul</li>
<li>État de São Paulo</li>
</region>
<settlement><li>São Paulo</li>
</settlement>
</list>
<tree><country name="Brésil"><region name="Rio Grande do Sul"><name sortKey="Soares, Andrey" sort="Soares, Andrey" uniqKey="Soares A" first="Andrey" last="Soares">Andrey Soares</name>
</region>
<name sortKey="Bastos, Diogo Assed" sort="Bastos, Diogo Assed" uniqKey="Bastos D" first="Diogo Assed" last="Bastos">Diogo Assed Bastos</name>
<name sortKey="Bastos, Diogo Assed" sort="Bastos, Diogo Assed" uniqKey="Bastos D" first="Diogo Assed" last="Bastos">Diogo Assed Bastos</name>
<name sortKey="Bastos, Diogo Assed" sort="Bastos, Diogo Assed" uniqKey="Bastos D" first="Diogo Assed" last="Bastos">Diogo Assed Bastos</name>
<name sortKey="Jardim, Denis" sort="Jardim, Denis" uniqKey="Jardim D" first="Denis" last="Jardim">Denis Jardim</name>
<name sortKey="Jardim, Denis" sort="Jardim, Denis" uniqKey="Jardim D" first="Denis" last="Jardim">Denis Jardim</name>
<name sortKey="Jardim, Denis" sort="Jardim, Denis" uniqKey="Jardim D" first="Denis" last="Jardim">Denis Jardim</name>
<name sortKey="Marques Montiero, Fernando Sabino" sort="Marques Montiero, Fernando Sabino" uniqKey="Marques Montiero F" first="Fernando Sabino" last="Marques Montiero">Fernando Sabino Marques Montiero</name>
<name sortKey="Marques Montiero, Fernando Sabino" sort="Marques Montiero, Fernando Sabino" uniqKey="Marques Montiero F" first="Fernando Sabino" last="Marques Montiero">Fernando Sabino Marques Montiero</name>
<name sortKey="Marques Montiero, Fernando Sabino" sort="Marques Montiero, Fernando Sabino" uniqKey="Marques Montiero F" first="Fernando Sabino" last="Marques Montiero">Fernando Sabino Marques Montiero</name>
<name sortKey="Marques Montiero, Fernando Sabino" sort="Marques Montiero, Fernando Sabino" uniqKey="Marques Montiero F" first="Fernando Sabino" last="Marques Montiero">Fernando Sabino Marques Montiero</name>
<name sortKey="Schutz, Fabio A" sort="Schutz, Fabio A" uniqKey="Schutz F" first="Fabio A" last="Schutz">Fabio A. Schutz</name>
<name sortKey="Schutz, Fabio A" sort="Schutz, Fabio A" uniqKey="Schutz F" first="Fabio A" last="Schutz">Fabio A. Schutz</name>
<name sortKey="Soares, Andrey" sort="Soares, Andrey" uniqKey="Soares A" first="Andrey" last="Soares">Andrey Soares</name>
<name sortKey="Soares, Andrey" sort="Soares, Andrey" uniqKey="Soares A" first="Andrey" last="Soares">Andrey Soares</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000088 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000088 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidSeniorV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:32965669 |texte= Use of Immunotherapy in Patients With Cancer During the COVID-19 Pandemic. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32965669" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidSeniorV1
This area was generated with Dilib version V0.6.37. |